Navigation Links
Jazz Pharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
Date:11/6/2007

ay be necessary. An archived version of the webcast will be available through November 20, 2007. Investors may participate in the conference call by dialing 1-866-770-7120 in the U.S., or 1-617-213-8065 outside the U.S., and entering passcode 57344568. A replay of this call will be available until November 20, 2007 at 1-888-286-8010 (U.S.), or 1-617-801-6888 (international), using the passcode 41294935.

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. For further information see http://www.JazzPharmaceuticals.com.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements, including, but not limited to, statements related to the potential regulatory approval and anticipated commercial launch of Luvox CR, the initiation of additional clinical trials of Jazz Pharmaceuticals' product candidates, the continued development of Jazz Pharmaceuticals' product candidates and potential regulatory developments, and the timing of study results. These forward-looking statements inherently involve significant risks and uncertainties. Jazz Pharmaceuticals' actual results and the timing of events could differ materially from those anticipated in such forward looking statements as a result of these risks and uncertainties, which include, without limitation, the risks that the FDA may not approve Luvox CR for marketing in the United States, and, if approved, when that approval will occur; risks related to the development of Jazz Pharmaceuticals' product candidates, including the risk that Jazz Pharmaceuticals may not initiate clinical trials on the timing currently anticipated or at all, or that study or clinical trial results may require Jazz Pharma
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
2. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
3. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
4. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
5. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
6. ACG Announces Major Gift by Salix Pharmaceuticals, Inc.
7. Anthera Pharmaceuticals, Inc. Appoints Donald Santel to Board of Directors
8. Elan Pharmaceuticals, Inc. Licenses Software and Databases From GeneGo
9. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
10. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
11. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Maintaining its commitment to improving life through better ... off in the spirit of Better Sleep Month, DUXIANA ... and to providing a therapeutic sleep experience, helping to ... Better Sleep Month, a result of the call to ... the Centers for Disease Control’s confirmation that insufficient sleep ...
(Date:5/23/2013)... To kick off barbecue season, fire up ... by cutting calories with simple tips from Retrofit weight ... calorie-overboard this summer. , “The powerful heat of the grill ... if you are not mindful of your selections, it can ... Registered Dietitian Amy Margulies. , Margulies advises clients to choose ...
(Date:5/23/2013)... Boulder, CO (PRWEB) May 23, 2013 ... fit education, is proud to announce the formation of ... and Alphamantis Technologies to offer a bike ... fit principles and aerodynamic assessment for time trial, road ... a two-day experience offered to bike fitters with a ...
(Date:5/23/2013)... 23 (HealthDay News) -- Mild to moderate iodine deficiency ... children,s brain development, British researchers report. Low levels ... diet appear to put her child at risk of ... the study authors found. Pregnant women can boost their ... the researchers suggested. The finding, published online May ...
(Date:5/23/2013)... war influences soldier PTSD , Soldiers returning home ... developing post-traumatic stress disorder if public support for a ... validation or invalidation shapes the level of distress soldiers ... The study involved two experiments that asked participants to ... one, having an actor show either interest or disgust ...
Breaking Medicine News(10 mins):Health News:DUXIANA®, Quality Bed Innovator, Celebrates Better Sleep Month and Launches Summer Health Campaign 2Health News:Fire It Up! Master Calories at the Grill with Retrofit Weight Loss 2Health News:Fire It Up! Master Calories at the Grill with Retrofit Weight Loss 3Health News:Retül, Ero Sports and Alphamantis Partner for Industry First Aero Fit Course 2Health News:Retül, Ero Sports and Alphamantis Partner for Industry First Aero Fit Course 3Health News:Low Prenatal Iodine May Affect Child's Brain Development 2Health News:Link between war support and PTSD, time it late in negotiations and courtship by narcissists 2Health News:Link between war support and PTSD, time it late in negotiations and courtship by narcissists 3
... and,customer PHI, Inc. celebrated the execution of options ... the milestone achievement of 20,000 fleet,hours with the ... Sikorsky Aircraft is a subsidiary of United Technologies ... ), Under the options contract, PHI ...
... linked to high blood pressure, preterm births, study finds ... viral infection -- especially herpes viruses -- may be ... birth, Australian researchers report. , The findings -- the ... in learning more about the cause of hypertension in ...
... examines large sections of the sentinel lymph node for genes ... and multiple surgeries, doctors say. , The GeneSearch Breast Lymph ... company, is being used at the Medical College of Georgia ... node, the first place breast cancer typically spreads. The sample ...
... February 22, 2008, WASHINGTON, Feb. 25 ... Services (CMS) payment bundling report,released earlier this week, ... advocates, dialysis professionals, care providers and manufacturers,working together ... kidney,disease and kidney failure -- applauds CMS for ...
... Society, WHITE PLAINS, N.Y., Feb. 25 When ... office products,splashed in luscious color, got the devastating news ... leukemia, it brought,things into perspective for her. It also ... Clay Presley, president and CEO,Carolina Pad & Paper (CPP), ...
... during the surgical treatment of retinal hemorrhages or injuries. The ... retina to the wall of the eye. There is a ... travel, at high altitudes, or under nitrous oxide anesthesia. This ... present for weeks after the surgical procedure. , In order ...
Cached Medicine News:Health News:Sikorsky Aircraft and PHI Celebrate Fleet Expansion and 20K Milestone at Heli-Expo 2Health News:Viral Infections Tied to Pregnancy Complications 2Health News:Test can reduce recurrence of breast cancer 2Health News:Test can reduce recurrence of breast cancer 3Health News:Statement by Dr. Edward Jones, Chairman of Kidney Care Partners in Response to CMS Payment Bundling Report 2Health News:Statement by Dr. Edward Jones, Chairman of Kidney Care Partners in Response to CMS Payment Bundling Report 3Health News:Designer's Young Cousin Inspiration Behind Colorful School and Office Supplies That Raise Awareness for Leukemia 2Health News:Designer's Young Cousin Inspiration Behind Colorful School and Office Supplies That Raise Awareness for Leukemia 3Health News:Designer's Young Cousin Inspiration Behind Colorful School and Office Supplies That Raise Awareness for Leukemia 4
(Date:5/23/2013)... DIEGO , May 23, 2013  MedVantx, Inc., ... consumer pharmaceutical distribution channel announced today the Company has ... to manage $1.5B in pharmaceutical products and the upgrade ... akin to cGMP facilities in its specialty home delivery ... The Company provides leading pharmaceutical manufacturers, physicians, health systems ...
(Date:5/23/2013)... 2013   BioLife Solutions , Inc. (OTC:BLFS), a ... hypothermic storage and cryopreservation freeze ... media manufacturer , today announced its participation at the ... 2013 this week in London ... Dr. Aby J. Mathew, BioLife,s Senior Vice President and ...
(Date:5/23/2013)... Mai 2013 Ranbaxy Laboratories ... von Daiichi Sankyo Co., Ltd. (im ... Mai die Maßnahmen bekannt, die Ranbaxy ... um sich der Angelegenheiten der vorhergehenden ... ). Daiichi Sankyo unterstützt ...
Breaking Medicine Technology:MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 2MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 3BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 2BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 3Ranbaxy kündigt Verbesserungen bei Geschäftsstandards und Qualitätssicherungsinitiativen an 2
... C, LymphoStat-B(R) for lupus and ABthrax(R) for inhalation anthrax ... trial of darapladib underway in chronic coronary heart disease ... $25 million net cash burn -ROCKVILLE, Md., Jan. 12 ... ) will announce its priority goals for 2009 and ...
... InterMune, Inc.,(Nasdaq: ITMN ) today announced ... Monday, January 12 at 8:30 a.m. EST to discuss ... virus (HCV) protease inhibitor ITMN-191,(R7227) in combination with Pegasys(R) ... HCV genotype 1. ITMN-191 is,being developed in collaboration with ...
Cached Medicine Technology:Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 2Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 3Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 4Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 5Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 6Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 7Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 8Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 9InterMune to Conduct Conference Call and Webcast to Discuss Results of Triple Combination Study of ITMN-191 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: